© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
December 21, 2021
Steven D. Nathan, MD, FCCP, and Fernando J. Martinez, MD, MS, share clinical pearls and advice for the management of IPF.
Expert pulmonologists comment on emerging therapies in the pipeline for the treatment of IPF.
Fernando J. Martinez, MD, MS, and Steven D. Nathan, MD, FCCP, share their personal experiences using pirfenidone and nintedanib in clinical practice and discuss the role of managing comorbidities for the treatment of IPF.
Experts in pulmonology discuss the safety and efficacy of pirfenidone and nintedanib for the management of IPF.
Noah Rindos, MD, Talks Fibroids, Adenomyosis and Pregnancy
Kausik Ray, MD: A Risk-Based Look at LDL Cholesterol Lowering
Jennifer Green, MD: Outcomes, Impact of SGLT2i, GLP-1 RA Combination Therapy